Aurisco Pharmaceutical Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 12, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	10,776	8,579	10,488	10,029	8,830	6,364
Market Cap Growth	31.01%	-18.20%	4.58%	13.58%	38.75%	-
Enterprise Value	10,726	8,317	10,056	9,726	8,296	5,718
Last Close Price	26.53	20.82	25.21	23.96	21.25	15.19
PE Ratio	24.96	24.18	36.24	47.54	52.34	40.48
Forward PE	23.69	18.69	30.47	39.82	-	-
PS Ratio	6.63	5.81	8.31	9.95	10.99	8.82
PB Ratio	4.24	3.68	5.33	5.96	5.86	4.59
P/TBV Ratio	4.52	3.95	5.68	6.46	6.02	4.74
P/FCF Ratio	277.40	-	130.89	-	-	114.29
P/OCF Ratio	28.18	25.81	27.20	60.27	43.81	29.67
EV/Sales Ratio	6.60	5.64	7.97	9.65	10.33	7.93
EV/EBITDA Ratio	18.50	17.78	28.49	35.61	35.42	25.54
EV/EBIT Ratio	22.01	21.53	36.07	46.71	45.40	29.80
EV/FCF Ratio	276.12	-	125.50	-	-	102.69
Debt / Equity Ratio	0.39	0.41	0.06	0.03	0.01	-
Debt / EBITDA Ratio	1.71	2.00	0.33	0.19	0.08	-
Debt / FCF Ratio	25.52	-	1.46	-	-	-
Net Debt / Equity Ratio	-0.02	-0.05	-0.22	-0.20	-0.28	-0.41
Net Debt / EBITDA Ratio	-0.09	-0.26	-1.22	-1.24	-1.82	-2.52
Net Debt / FCF Ratio	-1.28	0.58	-5.35	6.81	8.70	-10.13
Asset Turnover	0.42	0.46	0.55	0.54	0.49	0.55
Inventory Turnover	1.10	1.15	1.18	1.28	1.45	1.60
Quick Ratio	2.98	2.68	1.69	1.92	3.06	5.02
Current Ratio	4.30	3.85	2.73	3.38	4.87	6.91
Return on Equity (ROE)	17.65%	16.50%	15.83%	13.05%	11.63%	13.31%
Return on Assets (ROA)	7.85%	7.49%	7.56%	6.93%	7.02%	9.11%
Return on Invested Capital (ROIC)	17.41%	17.95%	16.99%	14.85%	16.68%	21.19%
Return on Capital Employed (ROCE)	13.60%	11.60%	13.40%	12.20%	12.00%	13.80%
Earnings Yield	3.94%	4.14%	2.76%	2.10%	1.91%	2.47%
FCF Yield	0.36%	-2.42%	0.76%	-0.50%	-0.56%	0.88%
Dividend Yield	1.09%	1.39%	0.87%	0.67%	0.61%	0.79%
Payout Ratio	29.85%	26.72%	23.15%	24.81%	28.52%	22.90%
Buyback Yield / Dilution	3.69%	2.21%	-0.48%	-1.00%	-7.31%	-4.58%
Total Shareholder Return	4.77%	3.60%	0.40%	-0.33%	-6.69%	-3.79%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.